Can at-home semi-quantitative pregnancy tests serve as a replacement for clinical follow-up of medical abortion? A US study

Contraception. 2012 Dec;86(6):757-62. doi: 10.1016/j.contraception.2012.06.005. Epub 2012 Aug 13.

Abstract

Background: Medical abortion in the United States requires clinic-based follow-up, representing additional time and cost to women and clinics. We studied a semi-quantitative home pregnancy test as a possible replacement for in-person follow-up.

Study design: Four hundred and ninety women participated in the clinical study and used a pregnancy test to determine baseline human chorionic gonadotropin (hCG) on the day of mifepristone administration and follow-up hCG 1 week later. One hundred and eighty-nine other women completed a user comprehension survey. Accuracy, feasibility and acceptability of the test were assessed in both the clinical study and the survey.

Results: The test identified the one ongoing pregnancy in the clinical study cohort. Sensitivity and specificity were calculated at 100.0% and 97.0%. The majority of participants in both the clinical study and the user comprehension survey found the test to be "very easy" or "easy" to use.

Conclusion: At-home follow-up with a semi-quantitative pregnancy test is feasible for service delivery in the United States.

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Abortifacient Agents, Nonsteroidal / administration & dosage*
  • Abortifacient Agents, Steroidal / administration & dosage*
  • Abortion, Induced*
  • Adolescent
  • Adult
  • Chorionic Gonadotropin / urine
  • Cohort Studies
  • Feasibility Studies
  • Female
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Lost to Follow-Up
  • Middle Aged
  • Mifepristone / administration & dosage*
  • Misoprostol / administration & dosage*
  • Patient Satisfaction
  • Pregnancy
  • Pregnancy Tests*
  • Pregnancy, Unwanted / urine
  • Self Care* / adverse effects
  • United States
  • Young Adult

Substances

  • Abortifacient Agents, Nonsteroidal
  • Abortifacient Agents, Steroidal
  • Chorionic Gonadotropin
  • Misoprostol
  • Mifepristone